Please provide your email address to receive an email when new articles are posted on . Those in the upper range of negative fecal immunochemical test values were at higher risk for colorectal cancer.

Trastuzumab deruxtecan (T-DXd) in HER2-positive advanced breast cancer (ABC) with active CNS metastases: Real world data. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...